CLL is a heterogeneous disease with various genetic alterations, such as mutations in immunoglobulin heavy chain variable region (IGHV), MYC translocation, del(11q), del(13q), and del(17p) [514, 515]. The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.